Zattarin E, Marra A, Palazzo A, Griguolo G, et al. Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer. NPJ Breast Cancer 2025 Dec 13. doi: 10.1038/s41523-025-00859.
PMID: 41390667